Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

201
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
201
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

137
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
137
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

197
The pathophysiology of pneumonia involves the following steps:
197
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

1.8K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
1.8K
Pneumonia IV: Management01:28

Pneumonia IV: Management

283
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
283
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evolving Etiology of Community-Acquired Pneumonia.

Clinics in chest medicine·2026
Same author

Guidance for the Knowledge and Skills required for Antimicrobial Stewardship Leaders: an update from the Society for Healthcare Epidemiology of America, Infectious Diseases Society of America, Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.

Antimicrobial stewardship & healthcare epidemiology : ASHE·2026
Same author

Use of Procalcitonin as a Tool to Enhance Antimicrobial Stewardship.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Balance Versus Bias: Correcting Misinformation About the 2025 ATS Community-Acquired Pneumonia Guidelines.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Reply to the Infectious Diseases Society of America (IDSA) position statement.

American journal of respiratory and critical care medicine·2026
Same author

Reply to Smith et al., Salton et al., Smit et al., and Kraft and Despotovic.

American journal of respiratory and critical care medicine·2026

Related Experiment Video

Updated: May 22, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.0K

Pulmonary Infections in Adults: Community-Acquired Pneumonia.

Thomas M File1, Julio A Ramirez2

  • 1Infectious Disease Division - Summa Health, Akron, OH.

FP Essentials
|March 17, 2025
PubMed
Summary

Community-acquired pneumonia (CAP) is a common illness often caused by Streptococcus pneumoniae. Early diagnosis, pathogen-directed antimicrobial therapy, and preventive measures like vaccination are key to managing CAP effectively.

More Related Videos

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

14.6K
Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

22.6K

Related Experiment Videos

Last Updated: May 22, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.0K
A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

14.6K
Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

22.6K

Area of Science:

  • Pulmonary Medicine
  • Infectious Diseases
  • Microbiology

Background:

  • Community-acquired pneumonia (CAP) is a significant global health concern, particularly impacting vulnerable populations like the elderly and those with comorbidities.
  • The lung microbiome's role in CAP pathogenesis is an emerging area of research.
  • Streptococcus pneumoniae (pneumococcus) persists as the leading bacterial cause of CAP, despite vaccination efforts, with increasing macrolide resistance noted in the US.

Purpose of the Study:

  • To provide an overview of current understanding and management strategies for community-acquired pneumonia.
  • To highlight the diagnostic role of newer molecular testing methods.
  • To emphasize the importance of antimicrobial stewardship and preventive measures.

Main Methods:

  • Review of current literature and clinical guidelines for CAP diagnosis and treatment.
  • Discussion of diagnostic modalities including imaging, microbiological testing, and newer molecular assays (e.g., respiratory pathogen polymerase chain reaction panels).
  • Evaluation of antimicrobial therapy principles, duration, and the adjunctive role of biomarkers like procalcitonin.

Main Results:

  • CAP diagnosis relies on clinical signs, symptoms, and new imaging infiltrates.
  • Molecular testing aids in identifying viral pathogens, complementing traditional diagnostics.
  • Pathogen-directed antimicrobial therapy, guided by diagnostic studies, is crucial for optimal outcomes and stewardship.
  • A 3-5 day course of antibiotics is recommended with clinical improvement.

Conclusions:

  • Effective CAP management integrates timely diagnosis, pathogen-specific antimicrobial therapy, and judicious use of diagnostic tools.
  • Antimicrobial stewardship principles, including appropriate therapy duration guided by clinical response and biomarkers, are essential.
  • Preventive strategies, including smoking cessation and vaccination, are paramount in reducing CAP incidence and severity.